Singular observations can pave the way for major discoveries. Case reports and clinical studies highlight unique presentations, unexpected outcomes, or novel therapeutic approaches that contribute to clinical insight and academic discourse. Rare diseases, treatment complications, and atypical responses often surface first through detailed case documentation. While randomized trials dominate guideline development, well-structured case studies bridge clinical observation and research hypotheses. They provide invaluable teaching tools and can stimulate larger studies or policy shifts. With the rise of digital imaging, standardized reporting, and global publication platforms, sharing real-world data has become more accessible. Ethical considerations and patient consent remain paramount. Emphasis on methodological rigor, follow-up outcomes, and contextual interpretation ensures that these narratives support evidence-based advancement and knowledge dissemination within ophthalmology and beyond.







Title : Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom